GW Pharma (GWPH +1%) moves up after Canaccord initiated coverage earlier today with a Buy rating...


GW Pharma (GWPH +1%) moves up after Canaccord initiated coverage earlier today with a Buy rating and a $13 price target.

From other sites
Comments (1)
  • UpInSmoke
    , contributor
    Comments (32) | Send Message
     
    LOVE THIS STOCK, Don't buy GWPRF by accident. No information seems to be be available on how many shares underlie this secondary float from what is presumably a private investor or group. If anyone has any contact info for GWPRF, NOT GWPH, please post it here!!. Thanks, Been looking of a while.
    6 Jun 2013, 06:56 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs